Report Recommendations of the Commission on a Global Health Risk Framework for the Future
Set up by the U.S. National Academy in 2015 following the large-scale outbreaks of SARS, H1N1, Ebola, MERS-CoV and other emerging infectious diseases, the Commission comprises 17 members from different countries and experts in finance, government, R&D, health systems, and social sciences. The object of the Commission is to make recommendations for an effective global architecture for recognizing and mitigating the threat of epidemic infectious diseases. The Commission’s report, released in January 2016, argued that pandemic prevention and response is essential to both national security and global economic stability—not just a matter of health. Please join the Commission representatives, and health, business, and policy leaders from across the Asia-Pacific region for an intensive discussion of reforms that could better prepare the world for infectious disease threats in the future.
Watch Highlights from the Meeting
View full recording of the meeting >>
[space height=”10″]
Speakers included:
Victor J Dzau, Chair, International Oversight Group of the Commission; President, U.S. National Academy of Medicine
Lawrence Gostin, Commissioner; University Professor & Faculty Director, O’Neill Institute for National Global Health Law, Georgetown University; Director, WHO Collaborating Centre on Public Health Law & Human Rights
Gabriel M. Leung, Commissioner; Co-Director of WHO Collaborating Centre for Infectious Disease Epidemiology and Control; Dean, Li Ka Shing Faculty of Medicine, The University of Hong Kong
Peter Mathieson, President & Vice-Chancellor, The University of Hong Kong
Peter Sands, Commission Chair; Former Group Chief Executive Officer, Standard Chartered PLC; Senior Fellow, Mossavar-Rahmani Center for Business and Government, Harvard Kennedy School
Tan Chorh Chuan, Member, International Oversight Group of the Commission; President, National University of Singapore
For inquiries please email: hkusph@hku.hk
